XML 25 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Balance Sheets - USD ($)
$ in Millions
Jul. 02, 2023
Jan. 01, 2023
Current assets:    
Cash and cash equivalents (Note 4) $ 21,183 $ 14,127
Marketable securities 7,322 9,392
Accounts receivable, trade, less allowances $205 (2022, $203) 16,777 16,160
Inventories (Note 2) 12,888 12,483
Prepaid expenses and other 2,397 3,132
Total current assets 60,567 55,294
Property, plant and equipment at cost 51,218 49,253
Less: accumulated depreciation (30,642) (29,450)
Property, plant and equipment, net 20,576 19,803
Intangible assets, net (Note 3) 46,246 48,325
Goodwill (Note 3) 45,440 45,231
Deferred taxes on income (Note 5) 8,779 9,123
Other assets 10,078 9,602
Total assets 191,686 187,378
Current liabilities:    
Loans and notes payable 11,701 12,771
Accounts payable 10,443 11,703
Accrued liabilities 10,605 11,456
Accrued rebates, returns and promotions 15,672 14,417
Accrued compensation and employee related obligations 3,062 3,328
Accrued taxes on income (Note 5) 2,687 2,127
Total current liabilities 54,170 55,802
Long-term debt (Note 4) 33,901 26,888
Deferred taxes on income (Note 5) 3,627 6,374
Employee related obligations (Note 6) 6,461 6,767
Long-term taxes payable (Note 5) 2,536 4,306
Other liabilities 14,582 10,437
Total liabilities 115,277 110,574
Commitments and Contingencies (Note 11)
Shareholders’ equity:    
Common stock — par value $1.00 per share (authorized 4,320,000,000 shares; issued 3,119,843,000 shares) 3,120 3,120
Accumulated other comprehensive income (loss) (Note 7) (13,135) (12,967)
Retained earnings and Additional paid-in capital 129,381 128,345
Less: common stock held in treasury, at cost (521,700,000 and 506,246,000 shares) 44,217 41,694
Stockholders' Equity Attributable to Parent 75,149 76,804
Total Johnson & Johnson shareholders’ equity 76,409 76,804
Stockholders' Equity Attributable to Noncontrolling Interest 1,260 0
Total liabilities and shareholders’ equity $ 191,686 $ 187,378